|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-3-28
|
|
pubmed:abstractText |
Oral transmucosal fentanyl citrate (OTFC) is a solid form of fentanyl that delivers the drug through the oral mucosa. The clinical utility of multiple doses of OTFC in the treatment of "breakthrough" cancer pain is under evaluation. The aim of this study was to test the hypothesis that the pharmacokinetics of OTFC do not change with multiple dosing.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0003-3022
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
665-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10719944-Administration, Oral,
pubmed-meshheading:10719944-Adolescent,
pubmed-meshheading:10719944-Adult,
pubmed-meshheading:10719944-Analgesics, Opioid,
pubmed-meshheading:10719944-Female,
pubmed-meshheading:10719944-Fentanyl,
pubmed-meshheading:10719944-Half-Life,
pubmed-meshheading:10719944-Humans,
pubmed-meshheading:10719944-Injections, Intravenous,
pubmed-meshheading:10719944-Male,
pubmed-meshheading:10719944-Middle Aged,
pubmed-meshheading:10719944-Models, Biological,
pubmed-meshheading:10719944-Mouth Mucosa,
pubmed-meshheading:10719944-Nonlinear Dynamics,
pubmed-meshheading:10719944-Population,
pubmed-meshheading:10719944-Radioimmunoassay
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
|
|
pubmed:affiliation |
Department of Anesthesiology, University of Utah, Salt Lake City 84132, USA. talmage.egan@hsc.utah.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
